Cytologic features of proliferative breast disease: A study designed to minimize sampling error

Cancer

Volumn 90, Issue 1, 2000, Pages 33-40

  Frost, Andra R ^a,c   Tabbara, Sana O ^b   Poprocky, Linda A ^b   Weiss, Heidi ^a   Sidawy, Mary K ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Breast; Cytology; Ductal carcinoma in situ; Nonproliferative breast disease; Proliferative breast disease

Indexed keywords

ARTICLE; BREAST DISEASE; BREAST TUMOR; CANCER CYTODIAGNOSIS; CYTOARCHITECTURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BIOPSY; BREAST DISEASES; CYTODIAGNOSIS; DIAGNOSTIC ERRORS; HISTOCYTOCHEMISTRY; HUMANS; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC;

EID: 0034711994     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000225)90:1<33::AID-CNCR5>3.0.CO;2-5     Document Type: Article

References (24)

1. Koss LG. The palpable breast nodule: a cost-effectiveness analysis of alternate diagnostic procedures. The role of needle aspiration biopsy. Cancer 1993;72:1499-502.
2. Donegan WL. Evaluation of a palpable breast mass. N Engl J Med 1992;327:937-41.
3. DeMay RM. The breast. In: DeMay, editor. The art and science of cytopathology. Aspiration cytology, Volume II. Chicago: ASCP Press, 1996:847-937.
4. nd edition, Philadelphia: W. B. Saunders, 1997:731-80.
5. Wang HH, Ducatman BS, Eick D. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the beast on fine needle aspiration biopsy. Am J Clin Pathol 1989;92:736-40.
6. Bibbo M, Scheiber M, Cajulis R, Keebler CM, Wied GL, Dowlatshahi K. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions. Acta Cytol 1988;32:193-201.
7. Masood S, Frykberg ER, McLellan GL, Dee S, Bullard JB. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates. Diagn Cytopathol 1991;7:581-90.
8. Sneige N, Staerkel GA. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum Pathol 1994;25:485-92.
9. Abendroth CS, Wang HH, Ducatman BS. Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens. Am J Clin Pathol 1991;96:654-9.
10. Thomas PA, Cangiarella J, Raab SS, Waisman J. Fine needle aspiration biopsy of proliferative breast disease. Mod Pathol 1995;8:130-6.
11. Gangopadhyay M, Nijhawan R, Joshi K, Gupta S. Cytology of "significant" breast ductal proliferations. Acta Cytol 1997;41: 1112-20.
12. Dziura BR, Bonfiglio TA. Needle cytology of the breast: a qualitative study of the cells of benign and malignant ductal neoplasia. Acta Cytol 1979;23:332-40.
13. Dawson AE, Mulford DK, Sheils LA. The cytopathology of proliferative breast disease: comparison with features of ductal carcinoma in situ. Am J Clin Pathol 1995;103:438-42.
14. Sidawy MK, Stoler MH, Frable WJ, Frost AR, Masood S, Miller TR, et al. Interobserver variability in the classification of proliferative breast lesions by fine needle aspiration: results of the Papanicolaou Society of Cytopathology Study. Diagn Cytopathol 1998;18:150-65.
15. Frost AR, Aksu A, Kurstin T, Sidawy MK. Can nonproliferative breast disease and proliferative breast disease without atypia be distinguished by fine-needle aspiration cytology? Cancer (Cancer Cytopathol) 1997;81:22-8.
16. Page DL, Anderson TJ, Rogers LW. Carcinoma in situ (CIS). In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. New York: Churchill Livingstone, 1987:157-92.
17. Page DL, Anderson TJ, Rogers LW. Epithelial hyperplasia. In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. New York: Churchill Livingstone, 1987:120-45.
18. Silverstein MJ, Poller DN, Weisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-7.
19. Zhang J, Quan H, Ng J, Stepanavage ME. Some statistical methods for multiple endpoints in clinical trials. Control Clin Trials 1997;18:204-21.
20. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-21.
21. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, et al. Interobserver reproducibility in the diagnosis of proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-43.
22. Blumenfeld W, Hashmi N, Sagerman P. Comparison of aspirate, touch and scrape preparations simultaneously obtained from surgically excised specimens. Acta Cytol 1998; 42:1414-8.
23. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312:146-51.
24. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 1998;90: 1371-88.